Merck shells out $10 billion for London-based lung therapy firm Verona

Merck shells out  billion for London-based lung therapy firm Verona


Bloomberg | Bloomberg | Getty Images

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug.

Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, which generated nearly $30 billion in sales in 2024, but faces patent expiries starting in 2028.

In response, the company has ramped up deal-making to broaden its revenue base. The latest deal is Merck’s largest since its $10.8 billion buyout of Prometheus Biosciences in 2023.

It builds on the company’s portfolio of chronic lung disease treatments, including recently approved Winrevair and Enflonsia.

Merck will pay $107 per American depository share for London-based Verona, a premium of 23% to Verona’s last closing price on the Nasdaq. Verona’s U.S.-listed shares jumped 20% in premarket trading.

Verona, which is also listed in Frankfurt, rose into prominence with the approval of its inhalable, non-steroid treatment Ohtuvayre for patients with chronic obstructive pulmonary disease, also known as “smoker’s lung”, a common lung disease affecting nearly 16 million Americans.

Ohtuvayre was approved last year and brought in annual sales of $42.3 million. Jefferies analysts expect the drug to have peak annual sales of more than $3 billion.

The Financial Times first reported that Merck was nearing a deal to acquire Verona. Last month, FT reported that Merck held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion.



Source

Most Fed officials see rate cuts coming, but opinions vary widely on how many, minutes show
World

Most Fed officials see rate cuts coming, but opinions vary widely on how many, minutes show

Federal Reserve officials diverged at their June meeting about how aggressively they would be willing to cut interest rates, split between concerns over tariff-fueled inflation and signs of labor market weakness and economic strength. Minutes from the June 17-18 meeting released Wednesday showed that policymakers largely held to a wait-and-see position on future rate moves. […]

Read More
Nvidia hits  trillion market cap, first company to do so
World

Nvidia hits $4 trillion market cap, first company to do so

Nvidia CEO Jensen Huang attends a roundtable discussion at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris on June 11, 2025. Sarah Meyssonnier | Reuters Nvidia stock jumped more than 2% on Wednesday, topping a $4 trillion market cap for the first time as investors scooped […]

Read More
Samsung launches three new foldable smartphones as it fends off Chinese rivals
World

Samsung launches three new foldable smartphones as it fends off Chinese rivals

The Galaxy Z Fold 7 is super thin, measuring just 8.9 millimeters when closed and 4.2 millimeters when unfolded. Ryan Browne | CNBC Samsung on Wednesday launched three new folding smartphones — including thinner top-end devices and a cheaper version of its flip phone — as the tech giant looks to entice buyers to make the […]

Read More